GO:1901292 nucleoside phosphate catabolic process: Breakdown Pathways, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901292 (nucleoside phosphate catabolic process) describes the biochemical reactions that break down nucleoside phosphates, including nucleotides such as ATP, GTP, and their deoxy counterparts.
• Nucleoside phosphate catabolism is essential for nucleotide homeostasis, recycling of phosphate and nucleosides, and regulation of cellular energy charge.
• Key enzymes include nucleotidases, phosphatases, and nucleoside hydrolases that sequentially remove phosphate groups and sugar moieties.
• Dysregulation of nucleoside phosphate catabolism is linked to antiviral drug metabolism, cancer, and cardiovascular calcification.
• CRISPR knockout, point mutation, and knock-in models are powerful tools to dissect the function of genes in this pathway.
• Studying this process requires methods such as LC-MS metabolomics, enzyme assays, and CRISPR library screening to identify regulators.
Description
Nucleoside phosphate catabolic process (GO:1901292) is a fundamental biological process that encompasses the chemical reactions and pathways resulting in the breakdown of nucleoside phosphates. Nucleoside phosphates, such as adenosine triphosphate (ATP), guanosine triphosphate (GTP), and their deoxyribonucleotide counterparts, are central to cellular energy transfer, nucleic acid synthesis, and signal transduction. The catabolism of these molecules is critical for maintaining nucleotide pools, recycling phosphate, and regulating cellular metabolism. Understanding this process is essential for researchers studying energy homeostasis, drug metabolism, and diseases ranging from cancer to cardiovascular disorders. The breakdown of nucleoside phosphates occurs through the sequential action of enzymes that remove phosphate groups and cleave glycosidic bonds, ultimately yielding free nucleosides and phosphate. This process is not merely degradative; it is tightly regulated and integrated with salvage pathways to ensure cellular survival under stress. In this article, we explore the mechanisms, key genes, and research methods used to study nucleoside phosphate catabolic process, with a focus on how CRISPR-based models can accelerate discovery.
nucleoside phosphate catabolic process At A Glance
| GO ID | GO:1901292 |
|---|---|
| GO term | nucleoside phosphate catabolic process |
| Ontology | biological_process |
| Synonym | nucleoside phosphate breakdown; nucleoside phosphate catabolism; nucleoside phosphate degradation |
| Major function | Breakdown of nucleoside phosphates to nucleosides and phosphate |
| Related processes | Nucleotide catabolic process, nucleoside salvage, phosphate homeostasis |
| Key enzymes | Nucleotidases, phosphatases, nucleoside hydrolases |
| Cellular location | Cytosol, lysosome, extracellular space |
| Disease relevance | Antiviral drug metabolism, cancer, cardiovascular calcification |
What Is GO:1901292?
According to the Gene Ontology, nucleoside phosphate catabolic process (GO:1901292) is defined as the chemical reactions and pathways resulting in the breakdown of a nucleoside phosphate. This includes the hydrolysis of phosphate ester bonds and the subsequent degradation of the nucleoside moiety. The process is a subclass of the broader nucleoside phosphate metabolic process and is distinct from nucleotide catabolic process, which specifically refers to nucleotides (nucleoside phosphates with one or more phosphate groups). The term encompasses both enzymatic and non-enzymatic breakdown, though enzymatic pathways are predominant in vivo.
Why Is nucleoside phosphate catabolic process Important in Cell Biology?
Nucleoside phosphate catabolic process is vital for cellular function because it controls the levels of nucleotides and nucleosides, which are building blocks for nucleic acids and key signaling molecules. Proper regulation of this process ensures a balanced nucleotide pool, prevents toxic accumulation of nucleotides, and supports energy metabolism. In addition, many antiviral and anticancer drugs are nucleoside analogs that require activation or degradation through these pathways, making this process a critical determinant of drug efficacy and toxicity. Furthermore, dysregulation of nucleoside phosphate catabolism has been implicated in diseases such as calcific aortic valve disease, where phosphate metabolism plays a role. Therefore, understanding the enzymes and regulatory mechanisms of this process is essential for both basic biology and therapeutic development.
• Maintains nucleotide homeostasis by preventing accumulation of excess nucleoside phosphates.
• Recycles phosphate and nucleosides for salvage pathways and energy metabolism.
• Modulates the activity of nucleoside analog drugs used in antiviral and cancer therapy.
• Plays a role in cardiovascular calcification through phosphate metabolism.
• Influences immune responses by regulating extracellular nucleotide levels.
• Provides targets for CRISPR-based functional genomics to identify new drug targets.
• Contributes to the biosynthesis of nucleoside antibiotics in microorganisms.
• Is involved in the degradation of dietary nucleotides and xenobiotics.
• Affects cell proliferation and survival under stress conditions.
• Serves as a model for studying enzyme kinetics and metabolic pathways.
What Happens During nucleoside phosphate catabolic process?
Dephosphorylation of Nucleoside Phosphates
In simple terms: The first step is removing phosphate groups from molecules like ATP.
The catabolic process typically begins with the hydrolysis of phosphate ester bonds in nucleoside phosphates, such as ATP or GTP, by enzymes known as nucleotidases or phosphatases. These enzymes cleave the terminal phosphate group, producing nucleoside diphosphates and inorganic phosphate. This step is crucial for regulating the energy charge of the cell and generating substrates for further degradation. For example, ectonucleotidases on the cell surface hydrolyze extracellular ATP to adenosine, which can then be taken up by cells.
Conversion to Nucleosides
In simple terms: Next, the remaining phosphate groups are removed to produce nucleosides.
Following dephosphorylation, nucleoside monophosphates are further hydrolyzed by phosphatases to yield free nucleosides and phosphate. This step is often catalyzed by specific enzymes such as 5'-nucleotidases, which remove the last phosphate group. The resulting nucleosides can either be salvaged or further degraded. The balance between phosphorylation and dephosphorylation is critical for maintaining nucleotide pools.
Cleavage of Nucleosides to Bases and Sugars
In simple terms: Finally, the nucleoside is split into a nitrogenous base and a sugar.
In the final stage, nucleosides are cleaved by nucleoside hydrolases or phosphorylases to release the nitrogenous base (e.g., adenine, guanine) and the sugar moiety (ribose or deoxyribose). This step is essential for the complete breakdown of nucleoside phosphates and allows the recycling of bases and sugars. In some organisms, this step is catalyzed by nucleoside phosphorylases, which use inorganic phosphate to cleave the glycosidic bond, producing a free base and a sugar phosphate.
Regulation and Integration with Salvage Pathways
In simple terms: The breakdown products can be reused to make new nucleotides.
The catabolic process is tightly regulated and integrated with salvage pathways. The free bases and sugars generated can be recycled to synthesize new nucleotides, especially in rapidly dividing cells. Enzymes such as hypoxanthine-guanine phosphoribosyltransferase (HGPRT) salvage bases, while the catabolic enzymes are regulated by substrate availability and cellular energy status. This interplay ensures that the cell can adapt to changing metabolic demands and prevent the loss of valuable precursors.
Key Genes Involved in GO:1901292 nucleoside phosphate catabolic process
The following genes encode enzymes and regulators involved in nucleoside phosphate catabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NT5E | Ecto-5'-nucleotidase, hydrolyzes AMP to adenosine | Regulates extracellular adenosine levels; target in cancer and immune therapy |
| NT5C | Cytosolic 5'-nucleotidase, dephosphorylates nucleoside monophosphates | Involved in nucleotide homeostasis and drug metabolism |
| NT5M | Mitochondrial 5'-nucleotidase | Maintains mitochondrial nucleotide pools |
| ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase | Generates pyrophosphate; linked to cardiovascular calcification |
| CD73 | Ecto-5'-nucleotidase (same as NT5E) | Immune checkpoint; target for cancer immunotherapy |
| ADA | Adenosine deaminase, converts adenosine to inosine | Deficiency causes severe combined immunodeficiency |
| PNP | Purine nucleoside phosphorylase | Catalyzes cleavage of purine nucleosides; target in T-cell malignancies |
| APRT | Adenine phosphoribosyltransferase | Salvage enzyme; deficiency causes kidney stones |
| HPRT1 | Hypoxanthine phosphoribosyltransferase | Salvage enzyme; deficiency causes Lesch-Nyhan syndrome |
| XDH | Xanthine dehydrogenase/oxidase | Degrades purines to uric acid; target in gout |
| UPP1 | Uridine phosphorylase 1 | Cleaves uridine to uracil and ribose-1-phosphate |
| UPP2 | Uridine phosphorylase 2 | Similar to UPP1, tissue-specific |
| PYGM | Glycogen phosphorylase | Not directly nucleoside phosphate catabolism but related to phosphate metabolism |
| CANT1 | Calcium-activated nucleotidase 1 | Golgi nucleotidase; involved in proteoglycan synthesis |
| NTPDase1 | Ectonucleoside triphosphate diphosphohydrolase 1 | Hydrolyzes ATP and ADP; regulates purinergic signaling |
| NTPDase2 | Ectonucleoside triphosphate diphosphohydrolase 2 | Hydrolyzes ATP to ADP; involved in neurotransmission |
| NTPDase3 | Ectonucleoside triphosphate diphosphohydrolase 3 | Hydrolyzes ATP and ADP; expressed in pancreas |
| NTPDase8 | Ectonucleoside triphosphate diphosphohydrolase 8 | Hydrolyzes ATP and ADP; liver-specific |
How Is nucleoside phosphate catabolic process Regulated?
Nucleoside phosphate catabolic process is regulated at multiple levels. Transcriptional regulation of genes encoding nucleotidases and phosphatases responds to cellular energy status and stress. For example, hypoxia-inducible factors (HIFs) can induce the expression of ecto-5'-nucleotidase (CD73) under low oxygen conditions, increasing adenosine production. Post-translational modifications, such as phosphorylation and glycosylation, modulate enzyme activity. Additionally, the availability of substrates and allosteric regulation by nucleotides influence flux through the pathway. In microorganisms, the biosynthesis of nucleoside antibiotics involves pyridoxal-5'-phosphate-dependent alkyl transfer, highlighting the intersection with specialized metabolism.
nucleoside phosphate catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CD73 (NT5E) | Cancer immune evasion | Knockout in cancer cell lines to assess adenosine production |
| ENPP1 | Calcific aortic valve disease | Point mutation knock-in in mice to model mineralization |
| ADA | Severe combined immunodeficiency | Knockout in hematopoietic stem cells |
| PNP | T-cell immunodeficiency | Knockout in T-cell lines |
| HPRT1 | Lesch-Nyhan syndrome | Knockout in iPSCs to study purine metabolism |
Nucleoside Phosphate Catabolism in Cancer
Altered nucleoside phosphate catabolism is a hallmark of cancer metabolism. Cancer cells often upregulate ectonucleotidases such as CD73 to produce adenosine, which suppresses anti-tumor immune responses. High CD73 expression is associated with poor prognosis in various cancers, making it a target for immunotherapy. Additionally, nucleoside analogs used in chemotherapy rely on catabolic enzymes for activation or degradation, affecting drug efficacy.
Cardiovascular Calcification and Phosphate Metabolism
Dysregulated phosphate metabolism, including nucleoside phosphate catabolism, contributes to calcific aortic valve disease. ENPP1 generates pyrophosphate, a potent inhibitor of calcification, and its dysfunction leads to ectopic mineralization. Understanding the catabolic pathways that regulate phosphate levels is crucial for developing therapies for cardiovascular calcification.
Antiviral Drug Metabolism
Many antiviral drugs are nucleoside analogs that require intracellular phosphorylation to become active, but they can also be degraded by catabolic enzymes. The balance between activation and degradation determines drug efficacy and toxicity. For example, the catabolism of acyclovir and its analogs involves nucleoside phosphatases and hydrolases. Studying these pathways helps optimize antiviral therapies.
Immunodeficiency and Purine Catabolism
Deficiencies in purine catabolic enzymes cause severe immunodeficiencies. Adenosine deaminase (ADA) deficiency leads to accumulation of toxic deoxyadenosine, causing severe combined immunodeficiency (SCID). Similarly, purine nucleoside phosphorylase (PNP) deficiency results in T-cell immunodeficiency. These disorders highlight the importance of nucleoside phosphate catabolism in immune function.
From nucleoside phosphate catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate nucleoside phosphate catabolism? | CRISPR knockout in HEK293 or HeLa cells |
| What is the effect of a point mutation in enzyme Y? | CRISPR point mutation knock-in in cell lines |
| Can we tag enzyme Z to track its localization? | Knock-in of fluorescent tag using CRISPR |
| Does overexpression of gene W alter drug sensitivity? | CRISPR overexpression (CRISPRa) in cancer cells |
| Which genes are essential for catabolism under stress? | Genome-wide CRISPR library screening |
| How does a disease-associated SNP affect enzyme activity? | Knock-in of SNP in isogenic cell lines |
How to Study the nucleoside phosphate catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Levels of nucleoside phosphates and catabolites | Quantifying drug metabolism |
| Enzyme activity assay | Catalytic rate of nucleotidases/phosphatases | Characterizing recombinant enzymes |
| CRISPR knockout screening | Genes affecting catabolic flux | Identifying novel regulators |
| CRISPR activation (CRISPRa) | Overexpression of candidate genes | Testing gain-of-function |
| Fluorescent biosensors | Real-time nucleoside phosphate dynamics | Live-cell imaging |
| RNA-seq | Transcriptional changes in catabolic genes | Response to stress |
| Proteomics | Protein expression and modifications | Mapping pathway enzymes |
| Phosphate release assay | Inorganic phosphate production | High-throughput screening |
Metabolomics and LC-MS
Liquid chromatography-mass spectrometry (LC-MS) is the gold standard for quantifying nucleoside phosphates and their catabolic products in biological samples. This method allows direct measurement of nucleotide levels, providing insights into pathway flux. It is widely used to study drug metabolism and enzyme kinetics.
Enzyme Activity Assays
In vitro enzyme assays using recombinant proteins or cell lysates measure the catalytic activity of nucleotidases and phosphatases. These assays typically use fluorescent or radioactive substrates to monitor phosphate release. They are essential for characterizing enzyme kinetics and inhibitor screening.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate nucleoside phosphate catabolism. By coupling catabolic activity to a selectable reporter, researchers can isolate mutants with altered pathway activity. This approach has been used to discover new regulators of nucleotide metabolism.
Imaging and Biosensors
Genetically encoded fluorescent biosensors can monitor real-time changes in nucleoside phosphate levels in live cells. These tools enable spatial and temporal analysis of catabolic processes. They are particularly useful for studying compartmentalized metabolism.
How CRISPR Can Be Used to Study GO:1901292 nucleoside phosphate catabolic process
Knockout
CRISPR knockout is used to completely abolish the expression of genes involved in nucleoside phosphate catabolism, such as NT5E or ENPP1, to study their loss-of-function phenotypes. This approach helps determine whether a gene is essential for the pathway and can reveal compensatory mechanisms. Knockout cell lines are valuable for drug sensitivity testing.
Point Mutation
CRISPR point mutation knock-in introduces specific amino acid substitutions to mimic disease-associated mutations or to dissect catalytic residues. For example, mutating the active site of a nucleotidase can confirm its role in substrate specificity. This precision editing is crucial for understanding enzyme mechanism.
Knock-in
Knock-in of tags (e.g., GFP, FLAG) or reporter genes allows visualization and purification of catabolic enzymes. This enables studies of protein localization, interaction, and dynamics. Knock-in of disease alleles in isogenic cell lines provides a controlled system for functional studies.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression is used to increase the levels of catabolic enzymes to study gain-of-function effects. Overexpression can sensitize cells to nucleoside analogs or alter metabolic flux. This approach is useful for identifying rate-limiting steps in the pathway.
How EDITGENE Supports nucleoside phosphate catabolic process Research
Researchers studying nucleoside phosphate catabolic process-related genes often need to determine whether a candidate gene is causally involved in the pathway, and CRISPR-based models provide a robust way to establish causality. By combining knockout, point mutation, knock-in, and overexpression strategies, scientists can dissect the precise roles of enzymes and regulators in this essential metabolic process.
Contact EDITGENE today to design your custom CRISPR model for nucleoside phosphate catabolic process research.
Frequently Asked Questions About nucleoside phosphate catabolic process
What is nucleoside phosphate catabolic process?
It is the set of biochemical reactions that break down nucleoside phosphates, such as ATP and GTP, into nucleosides and phosphate, as defined by GO:1901292.
What genes are involved in nucleoside phosphate catabolic process?
Key genes include NT5E, NT5C, ENPP1, ADA, PNP, and NTPDases, which encode enzymes that hydrolyze nucleoside phosphates.
Why is nucleoside phosphate catabolism important for drug metabolism?
Many antiviral and anticancer drugs are nucleoside analogs that are activated or degraded by these pathways, affecting drug efficacy and toxicity.
How is nucleoside phosphate catabolic process studied?
Researchers use LC-MS metabolomics, enzyme assays, CRISPR screening, and fluorescent biosensors to study this pathway.
What diseases are linked to defects in nucleoside phosphate catabolism?
Defects are linked to severe combined immunodeficiency, Lesch-Nyhan syndrome, cardiovascular calcification, and cancer.
What is the role of CD73 in nucleoside phosphate catabolism?
CD73 (NT5E) is an ecto-5'-nucleotidase that hydrolyzes AMP to adenosine, regulating immune responses and cancer progression.
How can CRISPR help study nucleoside phosphate catabolic process?
CRISPR knockout, point mutation, and knock-in models allow precise manipulation of genes to determine their function in the pathway.
What are the substrates of nucleoside phosphate catabolism?
Substrates include ATP, ADP, AMP, GTP, GDP, GMP, and their deoxy counterparts, as well as nucleoside analogs.
Is nucleoside phosphate catabolism the same as nucleotide catabolism?
No, nucleoside phosphate catabolism is a broader term that includes nucleotides and other nucleoside phosphates, while nucleotide catabolism specifically refers to nucleotides.
What are the products of nucleoside phosphate catabolic process?
The products are free nucleosides, nitrogenous bases, sugars, and inorganic phosphate.
Conclusion
Nucleoside phosphate catabolic process (GO:1901292) is a central metabolic pathway that controls nucleotide homeostasis, energy balance, and drug metabolism. Its dysregulation contributes to cancer, immunodeficiencies, and cardiovascular disease. Advances in CRISPR technology and metabolomics are enabling researchers to dissect the precise roles of individual enzymes and regulators. EDITGENE offers a comprehensive suite of CRISPR services to support functional studies of this pathway, from knockout to knock-in and library screening. By leveraging these tools, the scientific community can uncover new therapeutic targets and biomarkers for diseases linked to nucleoside phosphate catabolism.
References
- 1. Novgorodtseva AI et al.. 2024. Synthesis and Properties of α-Phosphate-Modified Nucleoside Triphosphates.. Molecules 29(17) PMID: 39274969
- 2. Cui Z et al.. 2020. Pyridoxal-5'-phosphate-dependent alkyl transfer in nucleoside antibiotic biosynthesis.. Nat Chem Biol 16(8):904-911 PMID: 32483377
- 3. Wu W et al.. 2004. Chemoenzymatic preparation of nucleoside triphosphates.. Curr Protoc Nucleic Acid Chem Chapter 13:Unit 13.2 PMID: 18428922
- 4. Groaz E et al.. 2015. Nucleoside Phosphate-Conjugates Come of Age: Catalytic Transformation, Polymerase Recognition and Antiviral Properties.. Curr Med Chem 22(34):3980-90 PMID: 26597062
- 5. Gautam N et al.. 2020. Direct and indirect quantification of phosphate metabolites of nucleoside analogs in biological samples.. J Pharm Biomed Anal 178:112902 PMID: 31610397
- 6. Costanzo G et al.. 2007. Nucleoside phosphorylation by phosphate minerals.. J Biol Chem 282(23):16729-35 PMID: 17412692
- 7. Inouye H et al.. 1971. Anti-inosine antibodies.. Biochim Biophys Acta 240(4):594-603 PMID: 5166308
- 8. Mathieu P et al.. 2014. Basic mechanisms of calcific aortic valve disease.. Can J Cardiol 30(9):982-93 PMID: 25085215
